Jia Jie (Taiwan) Today
Jia Jie is selling for under 21.20 as of the 31st of January 2025; that is 1.17 percent decrease since the beginning of the trading day. The stock's lowest day price was 21.15. The performance scores are derived for the period starting the 11th of February 2023 and ending today, the 31st of January 2025. Click here to learn more.
Valuation
Check how we calculate scores
Jia Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Jia Jie's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Jia Jie or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Drugs (View all Themes) |
| Business Concentration | Drugs, Packaged Foods, Consumer Defensive (View all Sectors) |
Jia Jie Biomedical (4109) is traded on Taiwan OTC Exchange in Taiwan and employs 24 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.28 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Jia Jie's market, we take the total number of its shares issued and multiply it by Jia Jie's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Jia Jie Biomedical operates under Consumer Defensive sector and is part of Packaged Foods industry. The entity has 88.94 M outstanding shares.
Jia Jie Biomedical has accumulated about 141.1 M in cash with 4.37 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.05.
Check Jia Jie Probability Of Bankruptcy
Jia Jie Biomedical Risk Profiles
Although Jia Jie's alpha and beta are two of the key measurements used to evaluate Jia Jie's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.83 | |||
| Standard Deviation | 2.66 | |||
| Variance | 7.07 | |||
| Risk Adjusted Performance | (0.09) |
Jia Stock Against Markets
Jia Jie Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Jia Jie stock to make a market-neutral strategy. Peer analysis of Jia Jie could also be used in its relative valuation, which is a method of valuing Jia Jie by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Additional Tools for Jia Stock Analysis
When running Jia Jie's price analysis, check to measure Jia Jie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jia Jie is operating at the current time. Most of Jia Jie's value examination focuses on studying past and present price action to predict the probability of Jia Jie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jia Jie's price. Additionally, you may evaluate how the addition of Jia Jie to your portfolios can decrease your overall portfolio volatility.